Home
|
Survey
|
Payment
|
Talks & Presentations
|
Job Opportunities
Journals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Journal of Evidence-Based Medicine
1671-5144
2013 Issue 1
Meta-Analysis: Association of Apolipoprotein E Gene Polymorphism with Type 2 Diabetes Mellitus in Chinese Population
LONG Ai-mei;ZUO Yan-fang;HUANG Xiao-qing;SHEN Ming-jing;CHEN Hui
..............
page:57-60
Upfront Gefitinib/Erlotinib Treatment Followed by Concomitant Radiotherapy for Advanced Lung Cancer
FU Xiao-long;NIU Fei-yu
..............
page:41-42
T790M and Its Effect on Clinical Outcome of EGFR-TKI in Non-Small Cell Lung Cancer
CHENG Ying;GUO Long-hua
..............
page:30-33
Evidence-Based Treatment of A Nonketotic Diabetic Patient with Epilepsy
YAN Xin;WANG Wei-min;GUO Ni
..............
page:54-56
Clinical Modes of EGFR Tyrosine Kinase Inhibitor Failure and Subsequent Management in Advanced Non Small Cell Lung Cancer
HUANG Cheng;LIN Gen;GOU Lan-ying
..............
page:37-40
Drug Response Effect Evaluation in Targeted Era
WU Yi-long
..............
page:1-3
Meta Analysis on the Association between Adiponectin Gene +276G/T Single Nucleotide Polymorphisms and Coronary Atherosclerotic Heart Disease in Chinese Population
ZHANG Zai-wei;DING Shi-fang;ZHAO Ya-ling;LU Qing;JIANG Na;XIE Lin
..............
page:61-64
Efficacy of TKI Therapy in Lung Adenocarcinoma Patients with or without T790M Mutation——A Control Study
MA Sheng-lin;YIN Jing-yi
..............
page:34-36
xin xi dong tai
..............
page:后插1-后插2
Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
pan ; niu fei yu ; su wen mei ; zhao ning ; zheng shu zuo ; lei yuan yuan ; deng wei ; zhang na
..............
page:4-29
Regain of TKI Sensitivity Following A Drug Holiday for Patients with NSCLC Who Initially Responded to EGFR-TKI Treatment
LU Shun;LI Zi-ming;YANG Lu-lu
..............
page:50-53
EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
ZHOU Cai-cun;LIN Huan
..............
page:46-49,53
Assessment of Retreatment of Gefitinib in Patients with Non-Small-Cell Lung Cancer Who Previously Controlled to Gefitinib
ZHAO Ming-fang;HE Yan-yan
..............
page:43-45